166 related articles for article (PubMed ID: 10946278)
1. Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.
Pan Q; Ebanks RO; Isenman DE
J Immunol; 2000 Sep; 165(5):2518-27. PubMed ID: 10946278
[TBL] [Abstract][Full Text] [Related]
2. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
Inal JM; Schifferli JA
J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
[TBL] [Abstract][Full Text] [Related]
3. Identification of the C3b receptor-binding domain in third component of complement.
Becherer JD; Lambris JD
J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
[TBL] [Abstract][Full Text] [Related]
4. Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.
Press EM; Gagnon J
Biochem J; 1981 Nov; 199(2):351-7. PubMed ID: 6978710
[TBL] [Abstract][Full Text] [Related]
5. The binding of human complement component C4 to antibody-antigen aggregates.
Campbell RD; Dodds AW; Porter RR
Biochem J; 1980 Jul; 189(1):67-80. PubMed ID: 6906229
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).
Oran AE; Isenman DE
J Biol Chem; 1999 Feb; 274(8):5120-30. PubMed ID: 9988761
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
8. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Gigli I; Fujita T; Nussenzweig V
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
[TBL] [Abstract][Full Text] [Related]
10. Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
Fujita T; Tamura N
J Exp Med; 1983 Apr; 157(4):1239-51. PubMed ID: 6601177
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
[TBL] [Abstract][Full Text] [Related]
12. The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chain.
Hessing M; van 'T Veer C; Bouma BN
J Immunol; 1990 Apr; 144(7):2632-7. PubMed ID: 2319131
[TBL] [Abstract][Full Text] [Related]
13. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
15. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
Ebanks RO; Isenman DE
Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
[TBL] [Abstract][Full Text] [Related]
16. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
Taniguchi-Sidle A; Isenman DE
J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
Ebanks RO; Isenman DE
J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
Nagasawa S; Stroud RM
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal anti-human C4b antibodies: stabilization and inhibition of the classical-pathway C3 convertase.
Ichihara C; Nakamura T; Nagasawa S; Koyama J
Mol Immunol; 1986 Feb; 23(2):151-7. PubMed ID: 2422544
[TBL] [Abstract][Full Text] [Related]
20. Complement receptor is an inhibitor of the complement cascade.
Iida K; Nussenzweig V
J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
